Thomas L Gallagher

11PUBLICATIONS
24CO-AUTHORS
Gene and molecular therapyGenetically modified animalsMedical devicesDevelopmental genetics (incl. sex determination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 25, 2026
Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model.

|May 23, 2026
Long-term comparative analysis of AAV9-mediated gene replacement therapies for spinal muscular atrophy in mice.

|Apr 14, 2026
Immune Toxicities in AAV Gene Therapy: Overview for Clinicians.

Shestruma Parajuli, Thomas Gallagher, Terence R Flotte

|Aug 15, 2025
Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trial.

Florian Eichler, Oguz I Cataltepe, Rrita Daci

|Sep 28, 2024
Limb Perfusion Delivery of a rAAV1 Alpha-1 Antitrypsin Vector in Non-Human Primates Is Safe but Insufficient for Therapy.

Debora Pires-Ferreira, Darcy Reil, Qiushi Tang

|May 09, 2020
Tissue-specific disruption of Kbtbd2 uncovers adipocyte-intrinsic and -extrinsic features of the teeny lipodystrophy syndrome.

Zhao Zhang, Thomas Gallagher, Philipp E Scherer

Pageof 2

Frequent Collaborators

3 joint publications

Terence R Flotte

2 joint publications

Jun Xie

2 joint publications

Allison M Keeler

2 joint publications

Guangping Gao